Intellectus Partners, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 64 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Intellectus Partners, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$35,000
+40.0%
13,0000.0%0.01%
+33.3%
Q2 2018$25,000
-7.4%
13,0000.0%0.01%0.0%
Q1 2018$27,000
+3.8%
13,0000.0%0.01%
-10.0%
Q4 2017$26,000
+52.9%
13,0000.0%0.01%
+42.9%
Q3 2017$17,000
-15.0%
13,0000.0%0.01%
-22.2%
Q2 2017$20,000
-52.4%
13,0000.0%0.01%
-57.1%
Q1 2017$42,00013,0000.02%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders